What Researchers Did
Researchers reviewed the existing literature on the use and efficacy of hyperbaric oxygen therapy for treating osteoradionecrosis.
What They Found
Hyperbaric oxygen (HBO) therapy is considered effective for osteoradionecrosis, though optimal treatment parameters like pressure, exposure times, and frequency remain undefined. Most studies utilized HBO as an adjunctive treatment, with its efficacy as a primary therapy not yet established.
What This Means for Canadian Patients
Canadian patients with osteoradionecrosis may benefit from hyperbaric oxygen therapy, often in conjunction with other treatments like surgery. However, the precise treatment protocols for optimal outcomes, including specific pressures and durations, are not yet standardized.
Canadian Relevance
This study has no direct Canadian connection.
Study Limitations
The review highlighted that existing studies lack established optimal treatment parameters and have not confirmed hyperbaric oxygen's efficacy as a primary treatment.